Skip to content
Nonprofiteer
← UNITED STATES PHARMACOPEIAL CONVENTION INC

Form 990 for tax year 2024

Filed by UNITED STATES PHARMACOPEIAL CONVENTION INC.

Totals

Total revenue
$357,720,644
Total expenses
$333,614,948
Contributions and grants received
$23,758,628
Grants paid
$523,834
Program service revenue
$312,085,057
Investment income
$21,655,407
Other revenue
$221,552
Total assets, end of year
$788,657,741
Total liabilities, end of year
$182,029,433
Net assets or fund balances, end of year
$606,628,308
Program services expenses (Part IX)
$237,592,558
Management and general expenses
$95,013,067
Fundraising expenses
$1,009,323
Program service expenses (Part III)
$237,592,558

Program services were 71.2% of total expenses calculated — Part IX's program-services column over total expenses, both as filed.

Line items

Every line the filer filed in Parts VIII, IX and X, as filed and in filed order. Blank columns are left out, and the lines are not forced to add up to the totals above.

Revenue

Part VIII, the statement of revenue.

  • 1e · Government grants (contributions)

    $21,952,739

  • 1f · All other contributions, gifts and grants

    $1,805,889

  • 1g · Noncash contributions included above

    $1,805,889

  • 2a · Program service revenue: COMPENDIAL ACTIVITIES

    total $304,315,984 · related or exempt $304,315,984

  • 2b · Program service revenue: ALLIED COMPENDIAL ACT.

    total $5,295,692 · related or exempt $5,295,692

  • 2c · Program service revenue: NON-COMPENDIAL ACT.

    total $2,473,381 · related or exempt $2,419,584 · unrelated business $53,797

  • 3 · Investment income

    total $10,074,561 · excluded $10,074,561

  • 5 · Royalties

    total $129,204 · excluded $129,204

  • 7a · Gross sales of assets other than inventory

    securities $239,091,570

  • 7b · Less cost or other basis and sales expenses

    securities $227,405,976 · other assets $104,748

  • 7c · Gain or loss

    securities $11,685,594 · other assets -$104,748

  • 7d · Net gain or loss

    total $11,580,846 · excluded $11,580,846

  • 11a · Other revenue: MISCELLANEOUS REVENUE

    total $92,348 · excluded $92,348

  • 11e · Other revenue, total

    $92,348

Functional expenses

Part IX, the statement of functional expenses.

  • 1 · Grants to domestic organizations and governments

    total $293,187 · program services $293,187

  • 2 · Grants to domestic individuals

    total $80,645 · program services $80,645

  • 3 · Grants to foreign organizations and individuals

    total $150,002 · program services $150,002

  • 5 · Compensation of officers, directors and key employees

    total $6,912,990 · program services $3,104,924 · management and general $3,658,421 · fundraising $149,645

  • 7 · Other salaries and wages

    total $140,514,004 · program services $101,233,664 · management and general $38,685,684 · fundraising $594,656

  • 8 · Pension plan contributions

    total $13,077,593 · program services $9,255,412 · management and general $3,756,157 · fundraising $66,024

  • 9 · Other employee benefits

    total $10,985,178 · program services $7,774,546 · management and general $3,155,172 · fundraising $55,460

  • 10 · Payroll taxes

    total $9,902,351 · program services $7,008,196 · management and general $2,844,162 · fundraising $49,993

  • 11b · Fees: legal

    total $343,147 · management and general $343,147

  • 11c · Fees: accounting

    total $456,840 · management and general $456,840

  • 11d · Fees: lobbying

    total $258,010 · management and general $258,010

  • 11f · Fees: investment management

    total $1,173,322 · management and general $1,173,322

  • 11g · Fees: other

    total $27,106,900 · program services $19,420,980 · management and general $7,596,538 · fundraising $89,382

  • 12 · Advertising and promotion

    total $730,650 · program services $506,808 · management and general $220,124 · fundraising $3,718

  • 13 · Office expenses

    total $8,241,960 · program services $7,315,079 · management and general $926,842 · fundraising $39

  • 14 · Information technology

    total $17,678,048 · program services $3,597,832 · management and general $14,080,216

  • 16 · Occupancy

    total $5,669,751 · program services $2,032,012 · management and general $3,637,739

  • 17 · Travel

    total $5,289,739 · program services $4,570,009 · management and general $719,324 · fundraising $406

  • 19 · Conferences, conventions and meetings

    total $2,646,116 · program services $2,358,295 · management and general $287,821

  • 20 · Interest

    total $2,908,601 · management and general $2,908,601

  • 21 · Payments to affiliates

    total $36,507,699 · program services $33,789,673 · management and general $2,718,026

  • 22 · Depreciation, depletion and amortization

    total $11,051,342 · program services $5,338,533 · management and general $5,712,809

  • 23 · Insurance

    total $1,297,370 · management and general $1,297,370

  • 24a · Other expenses: COST OF GOODS SOLD

    total $20,651,102 · program services $20,651,102

  • 24b · Other expenses: VALIDATION &CALIBRATION

    total $3,453,263 · program services $3,308,979 · management and general $144,284

  • 24c · Other expenses: PUB/SUBSCRIPTIONS

    total $2,341,050 · program services $2,252,674 · management and general $88,376

  • 24d · Other expenses: EXHIBITS

    total $218,809 · program services $139,106 · management and general $79,703

  • 24e · All other expenses

    total $3,675,279 · program services $3,410,900 · management and general $264,379

Balance sheet

Part X, book values.

  • 1 · Cash, non-interest-bearing

    beginning of year $28,514,480 · end of year $37,786,886

  • 2 · Savings and temporary cash investments

    beginning of year $31,131,585 · end of year $25,941,585

  • 3 · Pledges and grants receivable

    beginning of year $7,154,593 · end of year $828,848

  • 4 · Accounts receivable

    beginning of year $48,602,810 · end of year $44,606,175

  • 8 · Inventories for sale or use

    beginning of year $69,203,646 · end of year $65,737,416

  • 9 · Prepaid expenses and deferred charges

    beginning of year $12,988,689 · end of year $10,830,119

  • 10a · Land, buildings and equipment: cost or other basis

    $248,253,399

  • 10b · Land, buildings and equipment: accumulated depreciation

    $128,289,706

  • 10c · Land, buildings and equipment, net

    beginning of year $126,101,073 · end of year $119,963,693

  • 11 · Investments: publicly traded securities

    beginning of year $291,583,862 · end of year $321,616,701

  • 12 · Investments: other securities

    beginning of year $77,660,533 · end of year $86,881,986

  • 15 · Other assets

    beginning of year $57,894,640 · end of year $74,464,332

  • 17 · Accounts payable and accrued expenses

    beginning of year $69,885,754 · end of year $69,379,739

  • 19 · Deferred revenue

    beginning of year $7,404,393 · end of year $8,208,573

  • 20 · Tax-exempt bond liabilities

    beginning of year $87,329,897 · end of year $82,673,571

  • 25 · Other liabilities

    beginning of year $23,481,788 · end of year $21,767,550

  • 27 · Net assets without donor restrictions

    beginning of year $562,734,079 · end of year $606,628,308

Mission and programs · 2024

Mission

USP'S MISSION IS TO IMPROVE GLOBAL HEALTH THROUGH PUBLIC STANDARDS AND RELATED PROGRAMS THAT HELP ENSURE THE QUALITY, SAFETY, AND BENEFIT OF MEDICINES AND FOODS.

Activities or mission (Part I)

TO IMPROVE THE HEALTH OF PEOPLE AROUND THE WORLD THROUGH PUBLIC STANDARDS AND (SEE SCHEDULE O) RELATED PROGRAMS THAT HELP ENSURE THE QUALITY, SAFETY, AND BENEFIT OF MEDICINES AND FOODS.

  • COMPENDIAL ACTIVITIES - SEE SCHEDULE O

    Expenses $205,689,189 · Revenue $304,315,984

  • NON-COMPENDIAL ACTIVITIES - SEE SCHEDULE O

    Expenses $26,780,945 · Revenue $2,473,381

  • ALLIED COMPENDIAL ACTIVITIES - SEE SCHEDULE O

    Expenses $5,122,424 · Grants $523,834 · Revenue $5,295,692

As filed on the 2024 return. The filer continues this part on Schedule O, which is not shown here.

Listed in Part VII

  • Dennis E Doherty MD

    CONVENTION PRESIDENT

    Total calculated
    $0
    Hours/week
    4
  • Todd K Abraham PhD MBA

    TREASURER

    Total calculated
    $0
    Hours/week
    4
  • Gregory E Amidon PhD

    PHARMACEUTICAL SCIENCES TRUSTEE

    Total calculated
    $0
    Hours/week
    4
  • Gwen Darien

    PUBLIC TRUSTEE

    Total calculated
    $0
    Hours/week
    4
  • Richard J Gilfillan MD MBA

    AT LARGE TRUSTEE

    Total calculated
    $0
    Hours/week
    4
  • Jesse L Goodman MD MPH

    MEDICAL SCIENCES TRUSTEE

    Total calculated
    $0
    Hours/week
    4
  • Laura Herman MBA Ma

    AT LARGE TRUSTEE

    Total calculated
    $0
    Hours/week
    4
  • Thomas Menighan Bspharmmba

    AT LARGE TRUSTEE

    Total calculated
    $0
    Hours/week
    4
  • Krishna Reddy Nallamalla MD

    AT LARGE TRUSTEE

    Total calculated
    $0
    Hours/week
    4
  • Stephen Ostroff MD

    MEDICAL SCIENCES TRUSTEE

    Total calculated
    $0
    Hours/week
    4
  • Julio Sanchez Y Tepoz Mscsjd

    AT LARGE TRUSTEE

    Total calculated
    $0
    Hours/week
    4
  • John Taylor JD

    AT LARGE TRUSTEE

    Total calculated
    $0
    Hours/week
    4
  • Susan Winckler Rph JD

    CHAIR AND PHARMA SCI TRUSTEE

    Total calculated
    $0
    Hours/week
    4
  • Ronald T Piervincenzi

    CHIEF EXECUTIVE OFFICER & EX-OFFICIO

    Total calculated
    $1,104,534
    From this org
    $975,149
    From related orgs
    $0
    Other
    $129,385
    Hours/week
    38

    Schedule J breakdown matched by us

    Base
    $760,961
    Bonus
    $188,946
    Other
    $25,242
    Deferred
    $117,452
    Nontaxable benefits
    $11,933
    Filer's total
    $1,104,534
  • Jakob Venema To 625

    EVP & CHIEF SCIENCE OFFICER

    Total calculated
    $708,056
    From this org
    $618,546
    From related orgs
    $0
    Other
    $89,510
    Hours/week
    38

    Schedule J breakdown matched by us

    Base
    $483,831
    Bonus
    $108,393
    Other
    $26,322
    Deferred
    $75,817
    Nontaxable benefits
    $13,693
    Filer's total
    $708,056
  • Anthony P Lakavage

    SECRETARY & SVP GLBL EA

    Total calculated
    $628,264
    From this org
    $545,170
    From related orgs
    $0
    Other
    $83,094
    Hours/week
    38

    Schedule J breakdown matched by us

    Base
    $403,592
    Bonus
    $115,411
    Other
    $26,167
    Deferred
    $74,100
    Nontaxable benefits
    $8,994
    Filer's total
    $628,264
  • Amanda D Cowley

    SVP, LEGAL, STRATEGY & PEOPLE

    Total calculated
    $608,543
    From this org
    $530,651
    From related orgs
    $0
    Other
    $77,892
    Hours/week
    38

    Schedule J breakdown matched by us

    Base
    $401,705
    Bonus
    $103,636
    Other
    $25,310
    Deferred
    $65,561
    Nontaxable benefits
    $12,331
    Filer's total
    $608,543
  • Stanley D Burhans

    CHIEF FINANCIAL OFFICER

    Total calculated
    $589,532
    From this org
    $507,875
    From related orgs
    $0
    Other
    $81,657
    Hours/week
    38

    Schedule J breakdown matched by us

    Base
    $382,280
    Bonus
    $99,428
    Other
    $26,167
    Deferred
    $67,397
    Nontaxable benefits
    $14,260
    Filer's total
    $589,532
  • Emily M Kaine

    SVP, GBL HEALTH & MANUFACTURING SVCS

    Total calculated
    $579,612
    From this org
    $527,212
    From related orgs
    $0
    Other
    $52,400
    Hours/week
    38

    Schedule J breakdown matched by us

    Base
    $422,519
    Bonus
    $102,883
    Other
    $1,810
    Deferred
    $42,046
    Nontaxable benefits
    $10,354
    Filer's total
    $579,612
  • Bruk Alemayehu

    SVP, GLOBAL LAB & TECHNICAL OPS

    Total calculated
    $482,723
    From this org
    $430,208
    From related orgs
    $0
    Other
    $52,515
    Hours/week
    38

    Schedule J breakdown matched by us

    Base
    $341,627
    Bonus
    $84,172
    Other
    $4,409
    Deferred
    $38,255
    Nontaxable benefits
    $14,260
    Filer's total
    $482,723
  • Jennifer Devine

    SVP, DOC STDS & COMP POLICY

    Total calculated
    $450,937
    From this org
    $419,352
    From related orgs
    $0
    Other
    $31,585
    Hours/week
    38

    Schedule J breakdown matched by us

    Base
    $345,080
    Bonus
    $71,950
    Other
    $2,322
    Deferred
    $31,510
    Nontaxable benefits
    $75
    Filer's total
    $450,937
  • John A Giannone To 824

    VP, COMPENDIAL OPERATIONS

    Total calculated
    $610,709
    From this org
    $552,057
    From related orgs
    $0
    Other
    $58,652
    Hours/week
    38

    Schedule J breakdown matched by us

    Base
    $173,110
    Bonus
    $64,616
    Other
    $314,331
    Deferred
    $53,500
    Nontaxable benefits
    $5,152
    Filer's total
    $610,709
  • Venkat Surendra Nath Koduru

    SVP REGIONS & PROGRAM OPS.(TO 6/25)

    Total calculated
    $528,358
    From this org
    $490,928
    From related orgs
    $0
    Other
    $37,430
    Hours/week
    38

    Schedule J breakdown matched by us

    Base
    $401,346
    Bonus
    $85,018
    Other
    $4,564
    Deferred
    $30,500
    Nontaxable benefits
    $6,930
    Filer's total
    $528,358
  • Debra J Perez

    CHIEF EQUITY OFFICER

    Total calculated
    $518,756
    From this org
    $449,620
    From related orgs
    $0
    Other
    $69,136
    Hours/week
    38

    Schedule J breakdown matched by us

    Base
    $344,688
    Bonus
    $77,868
    Other
    $27,064
    Deferred
    $64,063
    Nontaxable benefits
    $5,073
    Filer's total
    $518,756
  • Michael S Levy

    SVP, DIGITAL & INNOVATION

    Total calculated
    $486,751
    From this org
    $441,812
    From related orgs
    $0
    Other
    $44,939
    Hours/week
    38

    Schedule J breakdown matched by us

    Base
    $321,248
    Bonus
    $77,835
    Other
    $42,729
    Deferred
    $36,729
    Nontaxable benefits
    $8,210
    Filer's total
    $486,751
  • Fouad Atouf

    SVP, SCI-GLOB BIO

    Total calculated
    $476,218
    From this org
    $424,410
    From related orgs
    $0
    Other
    $51,808
    Hours/week
    38

    Schedule J breakdown matched by us

    Base
    $344,533
    Bonus
    $76,710
    Other
    $3,167
    Deferred
    $35,070
    Nontaxable benefits
    $16,738
    Filer's total
    $476,218

Compensation is as filed in Part VII: reportable pay from this organization and from related organizations, other compensation, and hours per week. The total, marked calculated, is our sum of the three dollar columns, with a blank column counted as $0; the form itself has no total. On a Form 990-EZ the columns are Part IV's instead, and on a Form 990-PF Part VIII's — compensation, contributions to benefit plans, and expense account — and the total sums those. A Schedule J breakdown is as filed: base pay, bonus, other, deferred compensation and nontaxable benefits from this organization, with any from related organizations beside each, and the filer's own total. It is shown with the Part VII listing of the same name on the same return. The form gives no key between the two, so that pairing is ours, and is marked matched by us.

Schedule J

Answered yes

  • 3 · Independent compensation consultant
  • 3 · Form 990 of other organizations
  • 3 · Compensation survey or study
  • 3 · Approval by the board or compensation committee
  • 4a · Severance or change-of-control payment
  • 4b · Supplemental nonqualified retirement plan
  • 7 · Other non-fixed payments

Answered no

  • 4c · Equity-based compensation arrangement
  • 5a · Pay contingent on this organization's revenues
  • 5b · Pay contingent on a related organization's revenues
  • 6a · Pay contingent on this organization's net earnings
  • 6b · Pay contingent on a related organization's net earnings
  • 8 · Paid under the initial-contract exception

The filer's explanations (Part III)

SCHEDULE J, PART I, LINE 4A:
DURING THE YEAR JOHN A. GIANNONE RECEIVED A SEVERANCE PAYMENT OF $258,300. THIS PAYMENT IS REPORTED AS OTHER REPORTABLE COMPENSATION ON PART II, COLUMN B (III).
SCHEDULE J, PART I, LINE 4B:
SUPPLEMENTAL NONQUALIFIED RETIREMENT PLAN DURING THE YEAR, CERTAIN INDIVIDUALS PARTICIPATED IN A NONQUALIFIED RETIREMENT PLAN. THE FOLLOWING INDIVIDUAL RECEIVED DEFERRED COMPENSATION DISTRIBUTIONS REPORTED ON SCHEDULE J, PART II, COLUMN B(III), OTHER REPORTABLE COMPENSATION. MICHAEL S. LEVY: $40,642 THE FOLLOWING INDIVIDUALS RECEIVED DEFERRED CONTRIBUTIONS (UNPAID AND ELIGIBLE FOR PAYMENT BASED ON VESTING AND PAYOUT SCHEDULE) REPORTED ON SCHEDULE J, PART II, COLUMN C, RETIREMENT AND OTHER DEFERRED COMPENSATION: RONALD T. PIERVINCENZI: $63,952. JAKOB VENEMA: $28,392 ANTHONY LAKAVAGE: $20,600 AMANDA D. COWLEY: $19,561 EMILY M. KAINE: $19,046 STANLEY D. BURHANS: $17,397 VENKAT SURENDRA NATH KODURU: $14,829 DEBRA J. PEREZ: $10,563 BRUK ALEMAYEHU: $9,506 FOUAD ATOUF: $9,150 JENNIFER DEVINE: $7,210 MICHAEL S. LEVY: $6,229 NURISHA R. WADE: $3,081 KENNETH B. ALEXANDER: $3,013
SCHEDULE J, PART I, LINE 7:
NON-FIXED PAYMENTS USP PROVIDES INCENTIVE COMPENSATION THAT IS COMMENSURATE WITH THE ACCOMPLISHMENT OF STATED GOALS. EACH INDIVIDUAL OFFICER, KEY EMPLOYEE, OR HIGHLY COMPENSATED EMPLOYEE HAS AN ANNUAL GOAL PLAN. BASED ON THE ACCOMPLISHMENT OF THOSE INDIVIDUAL STATED GOALS, THE INDIVIDUAL IS ELIGIBLE FOR A BONUS WHICH IS WITHIN A FIXED PERCENTAGE RANGE. BONUSES ARE CONSIDERED AS PART OF THE TOTAL COMPENSATION WHEN DETERMINING REASONABLENESS.

Part I's answers as filed. A line not listed was left unanswered; on lines 1a and 3 that means the box was not checked.

Grants on this return

The 10 largest by cash amount. The API serves every itemized grant.

Activities outside the United States

From Schedule F of this return, as filed.

Offices (line 3c)
15
Employees, agents and contractors (line 3c)
412
Expenditures and investments (line 3c)
$64,225,397

At most 25 lines of each part are listed here. Schedule F names no grantee, so each line is a region and its money.

Activities by region (Part I)

Region Offices Employees Activity Specific services Expenditures
SOUTH AMERICA 1 10 PROGRAM SERVICES COMPENDIAL $2,161,289
EAST ASIA AND THE PACIFIC 2 20 PROGRAM SERVICES COMPENDIAL $4,348,031
SOUTH ASIA 1 368 PROGRAM SERVICES COMPENDIAL $21,156,987
SUB-SAHARAN AFRICA 1 1 PROGRAM SERVICES COMPENDIAL $2,003,563
EUROPE (INCLUDING ICELAND & 1 4 PROGRAM SERVICES SALES OFFICE $2,941,145
SOUTH ASIA 1 1 PROGRAM SERVICES PQM OFFICE/USAID $185,899
EAST ASIA AND THE PACIFIC 1 6 PROGRAM SERVICES SALES OFFICE $1,153,900
SUB-SAHARAN AFRICA 5 2 PROGRAM SERVICES PQM OFFICE/USAID $2,737,405
EAST ASIA AND THE PACIFIC 1 0 PROGRAM SERVICES PQM OFFICE/USAID $837,231
SOUTH ASIA 1 0 PROGRAM SERVICES PQM OFFICE/USAID $688,859
SUB-SAHARAN AFRICA — — INVESTMENTS — $1,081,604
EAST ASIA AND THE PACIFIC — — INVESTMENTS — $2,857,806
EUROPE (INCLUDING ICELAND & — — INVESTMENTS — $1,854,252
SOUTH AMERICA — — INVESTMENTS — $2,348,113
SOUTH ASIA — — INVESTMENTS — $17,719,311
EUROPE (INCLUDING ICELAND & — — GRANTMAKING — $143,732
SUB-SAHARAN AFRICA — — GRANTMAKING — $6,270

Grants to organizations, by region (Part II)

The purpose of each grant is not shown.

Region Cash grants Manner of disbursement Noncash assistance Noncash description Valuation
MIDDLE EAST AND NORTH AFRICA $6,270 WIRE TRANSFER $0 — —
Grantees recognized as charities or with a 501(c)(3) equivalency letter (Part II line 2)
—
Other grantees (Part II line 3)
1

Grants to individuals, by region (Part III)

The type of assistance is not shown.

Region Recipients Cash grants Manner of disbursement Noncash assistance
EUROPE (INCLUDING ICELAND & GREENLAND) - ALBANIA, ANDORRA, AUSTRIA, BELGIU 1 $140,287 WIRE TRANSFER $0
Transferred property to a foreign corporation during the year (line 1)
Yes
Had an interest in a foreign trust (line 2)
No
Owned an interest in a foreign corporation (line 3)
Yes
Was a shareholder of a passive foreign investment company or qualified electing fund (line 4)
No
Owned an interest in a foreign partnership (line 5)
No
Had operations in or related to a boycotting country (line 6)
Yes

Related organizations on this return

Schedule R Part II: tax-exempt organizations related to the filer by control. It does not record shared board members or money.

Taxable family on this return

Schedule R Parts I, III and IV, as filed. These record ownership and control, not shared board members or money moved.

Disregarded entities

Part I: entities that legally are the filer and file no return of their own.

  • USP HOLDING LLC

    HOLDING · MD · income $39,362,030 · assets $29,335,406

    Directly controlled by USP

  • USP HOLDING INTERNATIONAL LLC

    HOLDING · MD · income $0 · assets $0

    Directly controlled by USP

Related corporations and trusts

Part IV: related organizations taxable as a corporation or trust.

  • PHARMATECH ASSOCIATES INC

    C · SCIENTIFIC · CA · 100% owned · share of income $5,889,391 · share of assets $636,500 · controlled entity

    Directly controlled by USP HOLDING

  • STRATIX LABS CORPORATION

    C · SCIENTIFIC · MN · 100% owned · share of income $284,162 · share of assets $10,111,600 · controlled entity

    Directly controlled by USP HOLDING

  • US PHARMACOPEIA INDIA PRIVATE LTD

    C · SCIENTIFIC · IN · 100% owned · share of income $23,733,636 · share of assets $30,699,008 · controlled entity

    Directly controlled by USPHUSPHI

  • US PHARMACOPEIA NIGERIA LTDGTE

    C · SCIENTIFIC · NI · 100% owned · share of income $674,661 · share of assets $9,260 · controlled entity

    Directly controlled by USPC

  • US PHARMACOPEIA STND RESEARCH & DEV

    C · SCIENTIFIC · CH · 100% owned · share of income $4,603,121 · share of assets $2,149,370 · controlled entity

    Directly controlled by USP HOLDING

  • US PHARMACOPEIA SWITZERLAND AG

    C · SCIENTIFIC · SZ · 100% owned · share of income $3,235,259 · share of assets $5,621,804 · controlled entity

    Directly controlled by USP HOLDING

  • US PHARMACOPEIA-SINGAPORE PTELTD

    C · SCIENTIFIC · SN · 100% owned · share of income $1,206,992 · share of assets $1,377,049 · controlled entity

    Directly controlled by USP HOLDING

  • UNITED STATES FARMACOPEIA BRASIL LTDA

    C · SCIENTIFIC · BR · 100% owned · share of income $2,059,798 · share of assets $2,722,174 · controlled entity

    Directly controlled by USPHUSPHI

  • USP KENYA

    C · SCIENTIFIC · KE · 100% owned · share of income $773,330 · share of assets $380,332 · controlled entity

    Directly controlled by USP HOLDING

  • US PHARMACOPEIAL CONVENTION SHANGHAI REP OFFICE

    C · SCIENTIFIC · CH · 100% owned · share of assets $6,607 · controlled entity

    Directly controlled by USPC

Provenance

Return type
form_990
Tax year
2024
Filed
12 November 2025
IRS schema version
2024v5.2
Source object
202513179349305956

Check it against the return as filed: the GivingTuesday Data Lake hosts a public copy of the original XML.

The source document this was parsed from is served over the API, which is where bulk and document access live.